Niemann-Pick diseases

Handbook of Clinical Neurology

Volumn 113, Issue , 2013, Pages 1717-1721

  Vanier, Marie T ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876849121     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59565-2.00041-1     Document Type: Chapter

References (21)

1. Labrune P., Bedossa P., Huguet P., et al. Fatal liver failure in two children with Niemann-Pick disease type B. J Pediatr Gastroenterol Nutr 1991, 13:104-109.
2. McGovern M.M., Aron A., Brodie S.E., et al. Natural history of type A Niemann-Pick disease: possible endpoints for therapeutic trials. Neurology 2006, 66:228-232.
3. McGovern M.M., Wasserstein M.P., Giugliani R., et al. A prospective, cross-sectional survey study of the natural history of Niemann-Pick disease type B. Pediatrics 2008, 122:e341-e349.
4. McGovern M.M., Wasserstein M.P., Kirmse B., et al. A phase 1 trial of recombinant human acid sphingomyelinase (rhASM). Enzyme replacement therapy in adults with non-neuronopathic ASM deficiency (ASMD Niemann-Pick B). Mol Genet Metab 2011, 102:S28.
5. Mendelson D.S., Wasserstein M.P., Desnick R.J., et al. Type B Niemann-Pick disease: findings at chest radiography, thin-section CT, and pulmonary function testing. Radiology 2006, 238:339-345.
6. Patterson M.C. A riddle wrapped in a mystery: understanding Niemann-Pick disease, type C. Neurologist 2003, 9:301-310.
7. Patterson M.C., Vecchio D., Jacklin E., et al. Long-term miglustat therapy in children with Niemann-Pick disease type C. J Child Neurol 2010, 25:300-305.
8. Patterson M.C., Hendriksz C.J., Walterfang M., et al. Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol Genet Metab 2012, 106:330-344.
9. Pavlu-Pereira H., Asfaw B., Poupctova H., et al. Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study. J Inherit Metab Dis 2005, 28:203-227.
10. Porter F.D., Scherrer D.E., Lanier M.H., et al. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med 2010, 2. 56ra81.
11. Schuchman E.H. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann-Pick disease. J Inherit Metab Dis 2007, 30:654-663.
12. Sevin M., Lesca G., Baumann N., et al. The adult form of Niemann-Pick disease type C. Brain 2007, 130:120-133.
13. Vanier M.T. Niemann-Pick disease type C. Orphanet J Rare Dis 2010, 5:16.
14. Vanier M.T., Millat G. Niemann-Pick disease type C. Clin Genet 2003, 64:269-281.
15. Vanier M.T., Suzuki K. Niemann-Pick diseases. Neurodystrophies and Neurolipidoses. Handbook of Clinical Neurology (revised series) 1996, 22:133-162. Elsevier, Amsterdam. H.W. Moser (Ed.).
16. Wasserstein M.P., Desnick R.J., Schuchman E.H., et al. The natural history of type B Niemann-Pick disease: results from a 10-year longitudinal study. Pediatrics 2004, 114:e672-e677.
17. Wasserstein M.P., Aron A., Brodie S.E., et al. Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann-Pick disease. J Pediatr 2006, 149:554-559.
18. Wijburg F.A., Sedel F., Pineda M., et al. Development of a suspicion index to aid diagnosis of Niemann-Pick disease type C. Neurology 2012, 78:1560-1567.
19. Wraith J.E., Imrie J. New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat. Ther Clin Risk Manag 2009, 5:877-887.
20. Wraith J.E., Baumgartner M.R., Bembi B., et al. Recommendations on the diagnosis and management of Niemann-Pick disease type C. Mol Genet Metab 2009, 98:152-165.
21. Wraith J.E., Vecchio D., Jacklin E., et al. Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial. Mol Genet Metab 2010, 99:351-357.